RICHMOND, Va., Sept. 30, 2002 (PRIMEZONE) -- Investors interested in small cap stocks can gather insights as executives from Intraware, Polydex Pharmaceuticals and SciQuest present at the Small Cap Stocks Forum. This free online forum gives investors the opportunity to hear directly from company executives and get their investment information straight from the source. The presentations will be accessible live at www.informedinvestors.com from 9:00 a.m.-10:30 a.m. EST, Thursday, October 3. The forum will also be archived and available on the site afterwards.
The Informed Investors Forum will include senior executives from Intraware (Nasdaq:ITRA), Ploydex Pharmaceuticals (Nasdaq:POLFX) and SciQuest (Nasdaq:SQST) speaking for approximately 30 minutes, each with PowerPoint presentations. As part of the forum, Investors are invited to email questions to the executives. The forum will also be archived on www.informedinvestors.com, www.vcall.com and www.investorconference.com.
Intraware, Inc. is a leading provider of global electronic software delivery and management (ESDM) solutions for software publishers worldwide. Intraware's unique and innovative delivery management solutions have attracted strategic relationships with industry leaders such as CorpSoft, Inc. and Sun Microsystems, Inc. Intraware's IT management solutions power business-to-business technology providers including: Business Objects SA, Documentum Inc., E.piphany Inc., Hyperion Software Inc., PeopleSoft Inc. and RSA Security Inc.
Polydex Pharmaceuticals Limited, through its subsidiaries, manufactures and sells Dextran and several of its derivatives, including Iron Dextran and Dextran Sulphate, veterinary pharmaceutical products and other specialty chemicals and cosmetic raw materials, with some related research and development. The Company is investigating the potential human applications of some of its products. Iron Dextran is a derivative of Dextran, produced by complexing Iron with Dextran. Iron extran is injected into most pigs at birth as a treatment for anemia. Dextran Sulphate is a specialty chemical that finds use in research applications of the pharmaceutical industry and other centers of chemical research. The Company also manufactures sterile injectable products, tablets and boluses, internal and external solutions, ointments and powders.
SciQuest is a software, information and services company that provides solutions to enhance research operations for pharmaceutical, biotechnology and other research-based organizations. SciQuest is focused on enabling researchers and their organizations to reduce costs, improve efficiencies, increase quality and speed the process of research. The Company's solutions are specifically designed to help scientists find, acquire and manage the critical research materials they use. These materials include chemical and biological compounds, laboratory supplies, and equipment. SciQuest also helps the suppliers of research materials to better service their customers through enhanced marketing channels and enriched product information. The Company's solutions can be utilized independently or integrated with leading software, automation equipment and supplier systems to enhance innovation, reduce costs and improve operational effectiveness. SciQuest customers include many of the world's leading pharmaceutical, biotechnology, chemical, academic and research organizations, such as Aventis, BayerCropScience, Corixa, Eisai Research Institute, FMC, GlaxoSmithKline, OSI Pharmaceuticals, Roche, Pfizer, Procter & Gamble and Schering-Plough. SciQuest is headquartered in Research Triangle Park, N.C., with offices in Philadelphia and London.
Informed Investors is the leading producer of online and offline industry-specific investment conferences for individual investors, and a member of the WILink suite of PrecisionIR(tm) services serving publicly traded companies and self-reliant investors.
About WILink
Since 1992, WILink plc (www.wilink.com) has been a leading provider of global investor relations and investment information services that attract and retain investors for public companies and mutual funds. WILink's PrecisionIR(tm) (www.precisionir.com) and PrecisionFM(tm) custom investor-marketing programs enable publicly traded companies and mutual funds to deliver tailored and compelling communications to a precisely targeted audience of investors. This year WILink will make more than 7 million investor introductions for over 4,200 corporate clients through PrecisionIR(tm) and PrecisionFM(tm) programs, which include the Annual Reports Service, the Fund Info Service, Informed Investors Forums (www.informedinvestors.com) and Vcall(r) webcasting (www.vcall.com). WILink's InstitutionalReach(tm) database and partnerships with over 230 leading financial channels in 14 countries including The Wall Street Journal, Financial Times, Barron's and Yahoo! Finance ensure clients targeted visibility within the investment community. WILink, Inc., a wholly owned subsidiary of WILink plc (LSE:WLK), began operations in Richmond, Va. in 1993.